COMMUNIQUÉS West-GlobeNewswire

REGENXBIO Announces IND Active for Phase I/II Trial of RGX-121 to Treat Mucopolysaccharidosis Type II
19/12/2017
Novel, one-time, direct-to-CNS treatment for MPS II focused toward potentially preventing the progression of cognitive deficits Clinical trial expected to enroll children with MPS II Anticipate beginning trial [...]
Asterias Biotherapeutics Completes Enrollment of Entire SCiStar Study
19/12/2017
FREMONT, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced enrollment and dosing of the last [...]
Axsome Therapeutics to Present at Biotech Showcase 2018
19/12/2017
NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Aclaris Therapeutics Initiates a Pilot Clinical Trial to Study ATI-50002 Topical in Patients with Vitiligo
19/12/2017
MALVERN, Pa., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and [...]
COPE Health Solutions expands COPE Health Scholars programs to Hawaii with Adventist Health Castle
19/12/2017
LOS ANGELES, Dec. 19, 2017 (GLOBE NEWSWIRE) -- COPE Health Solutions , a national health care advisory firm, is teaming up with Adventist Health Castle , a 160-bed hospital in Kailua, Hawaii, to launch its COPE Health [...]
ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares
19/12/2017
PORTLAND, Maine, Dec. 19, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (“ImmuCell” or the “Company”) (Nasdaq: ICCC ), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018
19/12/2017
BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Amphastar Announces Approval for Sodium Nitroprusside Injection, USP
19/12/2017
RANCHO CUCAMONGA, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that today the U.S. Food and Drug Administration (“FDA”) granted approval of its abbreviated new drug [...]
Transactions in relation to share buyback program
19/12/2017
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
HealthLynked Corp. Announces 12,926 Patient Member Profiles in Florida
19/12/2017
NAPLES, Fla., Dec. 19, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced it now has added 12,926 patient profiles in its Florida market. Dr. Michael Dent, Chairman and Chief Executive Officer [...]
Saniona AB: Saniona Spin-Out, Scandion Oncology Raises DKK 2 Million and Prepares for a Potential Public Listing
19/12/2017
PRESS RELEASE December 19, 2017 Saniona, a leading biotech company in the field of ion channels, today announced that its spin-out company, Scandion Oncology, has raised DKK 2 million in a private placement. Scandion [...]
OSE Immunotherapeutics Presents New Data Analysis Supporting Continued Development of OSE-127 in Inflammatory Bowel Diseases
19/12/2017
OSE-127 shown to have significant potential in patients with inflammatory bowel diseases (IBD) in therapeutic escape and with a strong medical need. Interleukin-7 receptor (IL-7R), target of OSE-127, overexpressed in [...]
BIOPHYTIS to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018
19/12/2017
PARIS, Dec. 19, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS) , a biotechnology company specializing in the development of drug candidates to treat age-related diseases, today announced that its [...]
NICOX :Réalisations de 2017, lancement commercial de VYZULTA et aperçu des activités pour 2018
19/12/2017
Communiqué de presse Nicox : Réalisations de 2017, lancement commercial de VYZULTA TM et aperçu des activités pour 2018 Nicox rejoint les quelques sociétés européennes de R&D ayant des médicaments approuvés par la [...]
Nicox Recaps 2017 Achievements, Provides Update on Commercial Availability of VYZULTA and Outlines 2018 Activities
19/12/2017
Press Release Nicox Recaps 2017 Achievements, Provides Update on Commercial Availability of VYZULTA TM and Outlines 2018 Activities Nicox joins the select group of European R&D companies with U.S. FDA approved [...]
Cannabis Wheaton Income Corp. Announces Exclusive Data Licensing Agreement With Prominent Cannabis Testing, Analysis and Rating Company
19/12/2017
VANCOUVER, British Columbia, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (“ Wheaton Income ” or the “ Company ”) is pleased to announce that it has entered into an [...]
Madrigal Pharmaceuticals Prices Public Offering of Common Stock
19/12/2017
CONSHOHOCKEN, Pa., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL ), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
Akers Biosciences Prices $6,000,000 Public Offering
19/12/2017
THOROFARE, N.J, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today announces the pricing of [...]
DiaMedica Therapeutics Completes Non-Brokered Private Placement
19/12/2017
MINNEAPOLIS, Dec. 18, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF) announced today the closing of its previously announced non-brokered private placement raising [...]

Pages